Vancouver Experience of Recombinant Human Platelet-Derived Growth Factor.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27871410.
- Also identified by DOI 10.1016/j.fcl.2016.07.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Joint arthrodesis utilizing autogenous bone graft remains the gold standard of treatment in fusion procedures of the foot and ankle. Graft harvest, however, has been associated with increased morbidity to patients as well as increased costs. With this in mind, multiple clinical studies have evaluated the efficacy of recombinant human platelet-derived growth factor (rh-PDGF-BB) with beta-tricalcium phosphate (B-TCP) to augment in foot and ankle arthrodesis with favorable results. These factors have led to the increased use of rh-PDGF-BB with B-TCP in Vancouver with good clinical results.
Medical subject headings
- Arthrodesis
- Calcium Phosphates
- Foot
- Fracture Healing
- Fractures, Ununited
- Proto-Oncogene Proteins c-sis
Anatomy
- ankle
- foot